Simplify Logo

Full-Time

Medical Science Liaison

Midwest

Confirmed live in the last 24 hours

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Healthcare
Biotechnology

Compensation Overview

$132.7k - $165kAnnually

+ Bonus + Incentives + Restricted Stock Units

Mid, Senior

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Marketing
Requirements
  • Terminal scientific and/or clinical degree – Ph.D., M.D., Pharm.D., and D.O.
  • At least 3 years of clinical or industry experience, preferably with an oncology/endocrinology focus.
  • Deep understanding of the peer-review publication process as demonstrated by at least one first-author article published in peer-reviewed journals.
  • Advanced understanding of the genetic basis for disease and modern genomic techniques is critical for success in this role.
  • Overall solid written and verbal communication skills to convey complex study results to audiences with varying degrees of scientific/clinical knowledge.
  • Outstanding interpersonal skills in understanding HCP needs and situational awareness to adapt content and communication style in real-time.
  • Team player working in synergy with marketing and sales team members providing accurate, comprehensive, and timely scientific and clinical support.
  • Demonstrating customer-centricity and passion for helping patients.
  • Familiarity with statistical methodologies.
  • A detail-oriented, organized self-starter with a strong ability to prioritize workload.
  • Location in proximity to airport hub and ability to travel within the defined region.
Responsibilities
  • Proactively identify, develop, and maintain strong relationships with academic and community physicians to promote understanding and adoption of Veracyte’s diagnostic tests.
  • Identify KOLs, stimulate investigator-initiated studies, and support them until study completion and article publication.
  • Provide tailored presentations to external HCPs at the request of sales team members.
  • Support the medical affairs team in collecting real-world evidence supporting the clinical utility of Veracyte’s tests.
  • Create and implement strategies supporting product improvements in collaboration with medical affairs, research and development, managed care, and sales teams.
  • Critically review the literature and build educational materials for external HCP and internal stakeholders.
  • Serve as a primary scientific and clinical resource to the marketing and sales team members providing medical updates, journal clubs, and MSL office hours.
  • Assist the managed care team in setting up applications for medical coverage by providing up-to-date scientific and clinical information supporting the clinical utility of Veracyte’s tests.
  • Provide conference coverage supporting the sales team and prepare a post-conference summary of relevant talks to the leadership team.

Veracyte specializes in cancer diagnostics by developing advanced genomic tests for early detection and diagnosis of various cancers. Their tests analyze genetic information from non-invasive samples like nasal swabs or tissue biopsies, providing insights into the presence and progression of cancer. This allows healthcare providers, such as hospitals and clinics, to make informed treatment decisions tailored to individual patients. Veracyte differentiates itself from competitors by focusing on non-invasive testing methods and continuously investing in research to expand its product offerings. The company's goal is to improve cancer diagnosis accuracy, enhance patient outcomes, and optimize the use of medical resources.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

4%

2 year growth

6%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a Bay Area Top Workplace for 11 consecutive years highlights a positive work environment and strong company culture.
  • Significant investments from firms like Aigen Investment Management and Quest Partners indicate strong financial backing and growth potential.
  • The upcoming launch of ClearLab and an MRD assay in 2026 showcases Veracyte's commitment to expanding its product portfolio and market reach.

What critics are saying

  • The competitive landscape in genomic diagnostics is intense, requiring Veracyte to continuously innovate to maintain its market position.
  • Dependence on successful clinical validation and regulatory approval for new tests can pose risks to product launch timelines.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection, setting it apart from traditional diagnostic methods.
  • Their Decipher Prostate and Bladder Genomic Classifiers offer superior prognostic information compared to standard approaches, enhancing treatment personalization.
  • Continuous investment in R&D and clinical validation ensures that Veracyte's tests remain at the forefront of cancer diagnostics.